Ramucirumab (Cyramza)

ramucirumab · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ramucirumab (Cyramza), covering 2014-10-08 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer